Importance of "targeted therapy" in EGFR-mutated Lung Cancer after Radiochemotherapy

被引：0
|
作者：
Mueller, Joerg Andreas [1 ,2 ]
Vordermark, Dirk [1 ]
机构：
[1] Univ Klin Halle Salle, Klin & Poliklin Strahlentherapie, Ernst Grube Str 40, D-06112 Halle, Saale, Germany
[2] Arbeitsgrp Junge DEGRO Deutsch Gesell Radioonkol e, Berlin, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2024年 / 200卷 / 10期
关键词：
CHEMORADIOTHERAPY; DURVALUMAB; NSCLC;
D O I：
10.1007/s00066-024-02284-w
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：921 / 923
页数：3
相关论文
共 50 条
  • [31] Afatinib After Progression on Osimertinib in Patients with EGFR-Mutated Lung Adenocarcinoma
    Aredo, J.
    Wakelee, H. A.
    Neal, J.
    Padda, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S619 - S619
  • [32] Small cell conversion complicated with hypertrophic pulmonary osteoarthropathy after targeted therapy for advanced EGFR-mutated lung adenocarcinoma: A case report
    Zhang, Sijia
    Chen, Leichong
    Zhu, Kuikui
    Meng, Rui
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2024, 67 (01) : 217 - 222
  • [33] Afatinib After Progression on Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer
    Aredo, Jacqueline, V
    Wakelee, Heather A.
    Neal, Joel W.
    Padda, Sukhmani K.
    CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2022, 30
  • [34] Platelet/lymphocyte ratio is a significant prognostic factor for targeted therapy in patients with EGFR-mutated non-small-cell lung cancer
    Liu, Kejun
    Jiang, Guanming
    Fang, Nianxin
    Cai, Limin
    Du, Wei
    Jia, Jun
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (12)
  • [35] Can we cure metastatic EGFR-mutated lung cancer today?
    Christopoulos, Petros
    TRANSLATIONAL CANCER RESEARCH, 2023, 12 (02) : 209 - 212
  • [36] Spatially resolved transcriptomics of cellular architecture in EGFR-mutated lung cancer
    Kerr, Daniel L.
    Wu, Wei
    Tamaki, Whitney
    Urisman, Anatoly
    Chou, Yu-Ting
    Gui, Philippe
    Jablons, David M.
    Bivona, Trever G.
    Blakely, Collin M.
    CANCER RESEARCH, 2022, 82 (12)
  • [37] EGFR amplification indicated poor prognosis in EGFR-mutated lung cancer with leptomeningeal metastases
    Geng, Di
    Niu, Ruina
    Li, Jinghong
    Guo, Sanxing
    Guo, Qianqian
    Huang, Siyuan
    Wang, Yurong
    CLINICAL RESPIRATORY JOURNAL, 2024, 18 (02):
  • [38] Adjuvant Osimertinib Improves Overall Survival in EGFR-Mutated Lung Cancer
    Kim, Edward S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (07) : 370 - 370
  • [39] Rociletinib in EGFR-Mutated Non-Small-Cell Lung Cancer
    Sequist, L. V.
    Soria, J-C
    Goldman, J. W.
    Wakelee, H. A.
    Gadgeel, S. M.
    Varga, A.
    Papadimitrakopoulou, V.
    Solomon, B. J.
    Oxnard, G. R.
    Dziadziuszko, R.
    Aisner, D. L.
    Doebele, R. C.
    Galasso, C.
    Garon, E. B.
    Heist, R. S.
    Logan, J.
    Neal, J. W.
    Mendenhall, M. A.
    Nichols, S.
    Piotrowska, Z.
    Wozniak, A. J.
    Raponi, M.
    Karlovich, C. A.
    Jaw-Tsai, S.
    Isaacson, J.
    Despain, D.
    Matheny, S. L.
    Rolfe, L.
    Allen, A. R.
    Camidge, D. R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (18): : 1700 - 1709
  • [40] EGFR-mutated squamous cell lung cancer and its association with outcomes
    Xia, Y.
    Jin, R.
    Peng, L.
    Shou, J.
    Wang, J.
    Jin, Y.
    Liang, F.
    Zhao, J.
    Wu, M.
    Li, Q.
    Zhang, B.
    Wu, X.
    Lan, F.
    Xia, L.
    Yan, J.
    Shao, Y.
    Stebbing, J.
    Shen, H.
    Li, W.
    ANNALS OF ONCOLOGY, 2021, 32 : S966 - S967
12345